The company has grown faster than the market in India and would be focused on research and development (R&D) spends going forward, said Uday Baldota, CFO, Sun Pharma.
first published: Feb 18, 2015 02:54 pm
A collection of the most-viewed Moneycontrol videos.
Live: Nifty extends gain to the second straight day but sees another weekly loss | Closing Bell
Live: Can Nifty extend gains and reclaim 26,000? | Opening Bell
FSS Simply Payments 2025 | AI in Payments: Building a Governance-First Future.
Live: Nifty reclaims 25,900, snaps 3-day losing streak; rupee falls to fresh low | Closing Bell
